In this episode, Samira Kiani discusses genetic means of regulating CRISPR to ensure safety and clinical applications in immunomodulation.

CRISPR Functional Genomics Miniseries, Episode #9:  Samira Kiani, CRISPR Safety

Mary Ann Liebert, Inc. is a leading company in the Scientific, Technical, and Medical knowledge and information industry. We are known for authoritative international publications in cutting-edge basic and translational biomedical research, with expanding scope in engineering, business, environment, and legal publications. These publications play an active and important role in advancing critical research and facilitating collaboration throughout the world in academia, industry, and government, and are also highly respected resources for legislators, policy makers, and educators.

Share CRISPR Functional Genomics Miniseries, Episode #9: Samira Kiani, CRISPR Safety

Sign up to save your podcasts

CRISPR Functional Genomics Miniseries, Episode #9: Samira Kiani, CRISPR Safety

CRISPR Functional Genomics Miniseries, Episode #9: Samira Kiani, CRISPR Safety